NGS Streamlines Biomarker Testing in Solid Tumors
Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment planning in solid tumors.
- Traina, MD, FASCO
- Demetria Smith-Graziani, MD, MPH
- Mark Agulnik, MD
- Mrinal M. Zuckerman, MD
- Naval G. Daver, MD
- Jessica Altman, MD
- Amir T. Roboz, MD
- Joshua Zeidner, MD
- Estelamari Rodriguez, MD, MPH
- Millie Das, MD
- Ruham Nasany, MD
- Anne Chiang, MD, PhD
- J. Douglas Miles, MD, PhD, FAAN
- Suma Satti, MD
- Zev A. Shah, MD, FASCO
- Syma Iqbal, MD
- Jennifer R.
No direct quotes available.
Author summary: NGS improves biomarker testing in solid tumors.
More News
- Lisbon’s Viral Pastel de Nata Is a Gift and a Curse
- Italian Fascists’ Love Affair With Israel Started Long Before Giorgia Meloni | Novara Media
- Landmark New Report Shows Canadian Lobbyists Represent Major Polluters Alongside Environmental Groups
- Cruelty and the human face of evil
- Protecting Your Loved Ones: Estate Law Attorneys in Woodbury, NJ You Can Trust | NorthPennNow
- Importing beef is not the solution | GABEL
- 400,000 Coloradans have cast votes so far
- WEEK 10 SEMOBALL TOP 10: Dexter back up, St. Vincent sneaks forward
- Giving States Waivers From Accountability Is a Dangerous Step Backward for Kids
- SJHN Daily: Celebrini Named NHL First Star of the Week